FICHA TECNICA REVOLADE 50 MG COMPRIMIDOS

Revolade NZ CMI revolade INDICATIONS • REVOLADE tablets are indicated for the treatment of chronic immune thrombocytopenia to increase platelet revolade Eltrombopag is sold under the brand name Revolade outside the US and is marketed by Novartis It is a thrombopoietin receptor agonist It is taken by mouth

revolade Eltrombopag Tablets 25 Mg Revolade 25mg Tablet is used to treat low platelet count due to chronic immune thrombocytopenic purpura or